Skip to main content

Risk and health care costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancer.

Publication ,  Conference
Weycker, D; Edelsberg, J; Kartashov, A; Barron, R; Lyman, GH
Published in: Journal of Clinical Oncology
May 20, 2011

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2011

Volume

29

Issue

15_suppl

Start / End Page

1050 / 1050

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Weycker, D., Edelsberg, J., Kartashov, A., Barron, R., & Lyman, G. H. (2011). Risk and health care costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancer. In Journal of Clinical Oncology (Vol. 29, pp. 1050–1050). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2011.29.15_suppl.1050
Weycker, D., J. Edelsberg, A. Kartashov, R. Barron, and G. H. Lyman. “Risk and health care costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancer.” In Journal of Clinical Oncology, 29:1050–1050. American Society of Clinical Oncology (ASCO), 2011. https://doi.org/10.1200/jco.2011.29.15_suppl.1050.
Weycker D, Edelsberg J, Kartashov A, Barron R, Lyman GH. Risk and health care costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011. p. 1050–1050.
Weycker, D., et al. “Risk and health care costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancer.Journal of Clinical Oncology, vol. 29, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2011, pp. 1050–1050. Crossref, doi:10.1200/jco.2011.29.15_suppl.1050.
Weycker D, Edelsberg J, Kartashov A, Barron R, Lyman GH. Risk and health care costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011. p. 1050–1050.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2011

Volume

29

Issue

15_suppl

Start / End Page

1050 / 1050

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences